SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Ron Sigourney who wrote (5029)7/31/1998 9:55:00 PM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
Ron:

Not a major selloff, quite. I guess that's subjective. On the day of the filing. July 15th?, the stock went to 26-3/4 during the trading day, I recall. Today, two weeks later, it closes at 20-3/8? I'd say that's a fair drop, though you might not call it a major selloff. I'm not really good at math, but would you say that it's more than a 25% drop from that intraday high? If I were long I'd consider a 25% drop in two weeks to be a major selloff. I would think if people were confident in the outcome that the stock would be moving up, rather than down.

Another way to look at it is that we went up to 26-3/4 from a basing at 20 and now we're retreating to that base of 20, as if no filing had occurred. So it wasn't a major selloff at all. Nothing happened.

<ggg>

I noticed you didn't take up the challenge about the Mexico sales. Not even one measly phon call?

Linda



To: Ron Sigourney who wrote (5029)8/18/1998 2:37:00 AM
From: Bill Wexler  Read Replies (2) | Respond to of 7041
 
The Zonagen fraud continues its price decline.

Just a quick reminder to all that:

1) Despite then nonstop hype and phony information posted by shills, hypesters, and illiterates (hi Myron)...I continue to be 100% correct about the Zonagen scam and its crooked managemnet.

2) Dauntless continues to avoid my questions about TXB...another Woodlands, Texas biotech fraud which was hyped by him and is closely associated with Zonagen. I correctly predicted the FDA rejection of Novastan and the stock's price collapse.

3) Zonagen will eventually and inevitably trade below 5 a share.